Back
Business
-
Briefly
HYDERABAD: GVK BIO on Monday that it had entered into a research agreement with Wyeth Pharmaceuticals, a division of the Wyeth group, to discover drug candidates focused on pre-defined discovery targets. GVK BIO would utilise in-house capabilities in discovery chemistry, informatics, biology and ADME to advance this programme. — Special Correspondent © Copyright 2000 - 2009 The Hindu |